Correlation between site specificity and electrophilic frontier values in the metabolic hydroxylation of biphenyl, di-aromatic and CYP2D6 substrates: a molecular modelling study

References

• Akhtar M. H. Fate of 3-phenoxybenzaldehyde: diphenyl ether cleavage, a major metabolite route in chicken. Journal of Agriculture and Food Chemistry 1990; 38: 1417–1422
   Google Scholar
• Appel K. E., Gorsdorf S., Scheper T., Bauszus M., Hildebrandt A. G. Enzymatic denitrosation of diphenylnitrosamine: activation or inactivation?. Archives of Toxicology 1987; 60: 204–208
   PubMedGoogle Scholar
• Barker S. A., Hsieh L. C., Mc Dowell T. R., Short C. R. Qualitative and quantitative analysis of the anthelmintic febendazole and its metabolites in biological matrices by direct exposure probe mass spectrometry. Biomedical and Environmental Mass Spectrometry 1987; 14: 161–165
   PubMedGoogle Scholar
• Bayraktar N., Kajbaf M., Jatoe S. D., Gorrod J. W. The oxidation of isomeric amino and acetamido-biphenyls by rat hepatic microsomal preparations. Archives of Toxicology 1987; 60: 91–92
   PubMedGoogle Scholar
• Burke A. B., Millburn P., Huckle K. R. The metabolism of 3-phenoxybenzoic acid and of benzoic acid in fish. Biochemistry Society Transactions 1988; 16: 24–25
   Google Scholar
• Cavalieri E. L., Rogan E. G., Cremonesi P., Devanesan P. D. Radical cations as precursors in the metabolic formation of quinones from benzo[a]pyrene and 6-fluorobenzo[a]pyrene. Biochemistry Pharmacology 1988; 37: 2173–2182
   PubMed Web of Science ®Google Scholar
• Chen T. H., Kuslikis B. I., Braselton W. E. Hydroxylation of 4,4′-methylenebis(2-chloroaniline) by canine, guinea-pig, and rat liver microsomes. Drug Metabolism and Disposition 1989; 17: 406–413
   PubMedGoogle Scholar
• Chui Y. C., Addison R. F., Law F. C. P. Studies on the pharmacokinetics and metabolism of 4-chlorodiphenyl ether in rats. Drug Metabolism and Disposition 1987; 15: 44–50
   PubMedGoogle Scholar
• Eichelbaum M. Polymorphic drug oxidation in humans. Federal Proceedings 1989; 43: 2298–2302
   Google Scholar
• Fleming I. Radical reactions. Frontier Orbitals and Organic Chemical Reactions. Wiley, New York 1989; 182–208
   Google Scholar
• Fukui K., Yonezawa T., Shingu H. A molecular orbital theory of reactivity in aromatic hydrocarbons. Journal of Chemical Physics 1952; 22: 722–725
   Google Scholar
• Guengerich F. P. Oxidation of 17 α-ethynylestradiol by human liver cytochrome P450. Molecular Pharmacology 1988; 33: 500–508
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Metabolic activation of carcinogens. Pharmaceutical Therapy 1992; 54: 17–61
   PubMed Web of Science ®Google Scholar
• Idle J. R., Smith R. L. Polymorphisms of oxidation at carbon centres of drugs and their clinical significance. Drug Metabolism Review 1979; 9: 301–317
   PubMed Web of Science ®Google Scholar
• Islam S. A., Wolf C. R., Lennard M. S., Sternberg M. J. E. A three dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation. Carcinogenesis 1991; 12: 2211–2219
   PubMed Web of Science ®Google Scholar
• Kannan N., Wakimoto T., Tatsukawa R. Possible involvement of frontier electrons in the metabolism of polychlorinated biphenyls. Chemosphere 1989; 18: 1955–1963
   Google Scholar
• Katagi T. Theoretical estimation of site specificity in the metabolic hydroxylation of synthetic pyrethroids. Journal of Pesticide Science 1990; 15: 427–433
   Google Scholar
• Koymans L., Van Lenthe J. H., Donne-Op Den Kelder G. M., Vermeulen N. P. E. Mechanism of activation of phenacetin to reactive metabolites by cytochrome P-450: a theoretical study involving radical intermediates. Molecular Pharmacology 1990; 37: 452–460
   PubMed Web of Science ®Google Scholar
• Koymans L., Vermeulen N. P. E., Van Acker S. A. B. E., De Koppele J. M., Heykants J. J. P., Lavrijsen K., Meuldermans W., Donne-Op-Den Kelder G. M. A predictive model for substrates of Cytochrome P450-debrisoquine (2D6). Chemical Research and Toxicology 1992; 5: 211–219
   PubMed Web of Science ®Google Scholar
• Lakshmi V. M., Mattammal M. B., Spry L. A., Kadlubar F. F., Zenser T. V., Davis B. B. Metabolism and disposition of benzidine in the dog. Carcinogenesis 1990; 11: 139–144
   PubMedGoogle Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Structural requirements for substrates of cytochromes P-450 and P-448. Chemical and Biological Interactions 1987; 64: 39–60
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Molecular orbital studies of oxygen activation and mechanisms of cytochromes P-450-mediated oxidative metabolism of xenobiotics. Chemical and Biological Interactions 1989; 70: 263–280
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Tamburini P. P., Gibson G. G. The interaction of a homologous series of hydrocarbons with hepatic cytochrome P450. Molecular orbital-derived electronic and structural parameters influencing the hemoprotein spin state. Chemical and Biological Interactions 1986; 58: 289–299
   PubMed Web of Science ®Google Scholar
• Meyer U. A., Skoda R. C., Zanger U. M. The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms. Pharmaceutical Therapeutics 1990; 46: 297–308
   PubMed Web of Science ®Google Scholar
• Mohamadi F., Richards N. G. J., Guida W. C., Liskamp R., Caufield G., Chang C., Hendrickson T., Still W. C. Macromodel—an integrated software system for modelling organic and bioorganic molecules using molecular mechanics (v 3.5X). Journal of Computational Chemistry 1990; 11: 440–467
   Web of Science ®Google Scholar
• Nakagawa Y., Tayama S. Formation of o-phenylphenol glutathione conjugates in the rat liver. Xenobiotica 1989; 19: 499–507
   PubMed Web of Science ®Google Scholar
• Ortiz De Montellano P. R. Cytochrome P-450 catalysis: radical intermediates and dehydrogenation reactions. Trends in Pharmacological Sciences 1989; 10: 354–359
   PubMed Web of Science ®Google Scholar
• Paulson G. D., Feil V. J. The disposition of N-(4,6-dimethyl-2-pyrimidinyl)-benzene (U-14C]sulphonamide in the rat. Drug Metabolism and Disposition 1987; 15: 671–675
   PubMedGoogle Scholar
• Roy S. D., Hawes E. M., Mc Kay G., Korchinski E. D., Midha K. K. Metabolism of methoxyphenamne in extensive and poor metabolisers of debrisoquin. Clinical and Pharmacological Therapeutics 1985; 38: 128–133
   PubMed Web of Science ®Google Scholar
• Roy S. D. Kinetics of in vitro metabolism of methoxyphenamine in rats. Xenobiotica 1990; 20: 55
   PubMed Web of Science ®Google Scholar
• Sasame H. A., Liberato D. J., Gillette J. R. The formation of a glutathione conjugate derived from propranolol. Drug Metabolism and Disposition 1987; 15: 349–355
   PubMed Web of Science ®Google Scholar
• Shaw L., Lennard M. S., Tucker N. D., Bax S., Woods H. F. Irreversible binding and metabolism of propranolol by human liver microsomes: relationship to polymorphic oxidation. Biochemical Pharmacology 1987; 36: 2283–2288
   PubMed Web of Science ®Google Scholar
• Talaat R. E., Nelson W. L. Regioisomeric aromatic dihydroxylation of propranolol. Drug Metabolism and Disposition 1988; 16: 207–211
   PubMedGoogle Scholar
• Ward S. A., Walle T., Walle U. K., Wilkinson G. R., Branch R. A. Propranolols metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities. Clinical and Pharmacological Therapeutics 1989; 45: 72–79
   PubMed Web of Science ®Google Scholar